Mark Pollack to Follow-Up Studies
This is a "connection" page, showing publications Mark Pollack has written about Follow-Up Studies.
Connection Strength
0.480
-
Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry. 2010 Feb 15; 67(4):365-70.
Score: 0.062
-
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy. J Clin Psychiatry. 2008 Mar; 69(3):400-5.
Score: 0.056
-
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry. 2006 Feb 01; 59(3):211-5.
Score: 0.047
-
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998 Nov; 55(11):1010-6.
Score: 0.029
-
Long-term course and outcome of panic disorder. J Clin Psychiatry. 1997; 58 Suppl 2:57-60.
Score: 0.026
-
Relationship of antecedent stressful life events to childhood and family history of anxiety and the course of panic disorder. J Affect Disord. 1996 Nov 25; 41(2):135-9.
Score: 0.026
-
The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am. 1995 Dec; 18(4):785-801.
Score: 0.024
-
Cognitive behavior therapy for treatment-refractory panic disorder. J Clin Psychiatry. 1994 May; 55(5):200-5.
Score: 0.021
-
Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder. J Clin Psychopharmacol. 1993 Aug; 13(4):257-63.
Score: 0.020
-
Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug; 74(8):786-92.
Score: 0.020
-
D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry. 2013 Jun 01; 73(11):1054-8.
Score: 0.020
-
Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther. 2012 Jan; 18(1):21-7.
Score: 0.017
-
Fluoxetine treatment of cocaine abuse in heroin addicts. J Clin Psychiatry. 1991 Jan; 52(1):31-3.
Score: 0.017
-
Long-term management of panic disorder. J Clin Psychiatry. 1990 May; 51 Suppl:11-3; discussion 50-3.
Score: 0.016
-
Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry. 2007 Oct; 64(10):1153-60.
Score: 0.014
-
Anxiety is associated with impulsivity in bipolar disorder. J Anxiety Disord. 2008 Jun; 22(5):868-76.
Score: 0.014
-
Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up. J Clin Psychopharmacol. 1986 Oct; 6(5):302-4.
Score: 0.013
-
Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord. 2006 Aug; 94(1-3):191-7.
Score: 0.012
-
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series. Behav Res Ther. 1999 Aug; 37(8):763-70.
Score: 0.008
-
Pattern of placebo response in panic disorder. Psychopharmacol Bull. 1995; 31(2):273-8.
Score: 0.006
-
Predicting prospective episodes of depression in patients with panic disorder: a longitudinal study. J Consult Clin Psychol. 1994 Apr; 62(2):359-65.
Score: 0.005
-
Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
Score: 0.005
-
Follow-up study of formerly hospitalized voluntary psychiatric patients: the first two years. Am J Psychiatry. 1966 Apr; 122(10):1102-9.
Score: 0.003